<?xml version="1.0" encoding="UTF-8"?>
<fig id="fig0005">
 <label>Fig. 1</label>
 <caption>
  <p>Development of stable rZNS1-His-expressing HEK293 cells. 
   <bold>(A)</bold> Immunostaining of untransduced (UTD) HEK293 cells, parental, 1E4, 1E4-C9 and 1E4-D11 rZNS1-His HEK293 cells with ZNS1 mouse polyclonal sera. Scale bar, 25 μm. 
   <bold>(B)</bold> Determination of the percentage of positive rZNS1-His-expressing cells assessed by flow cytometry in UTD, parental, 1E4, 1E4-C9 and 1E4-D11 rZNS1-His HEK293 cells. Only secondary Ab was used as control. 
   <bold>(C-D)</bold> Western blot analysis of cell extracts 
   <bold>(C)</bold> and supernatants 
   <bold>(D)</bold> of UTD, 1E4, 1E4-C9 and 1E4-D11 rZNS1-His HEK293 cells with anti-ZNS1 monoclonal antibody. GAPDH 
   <bold>(C)</bold> and Coomassie brilliant blue staining 
   <bold>(D)</bold> were used as loading controls. The position of the molecular mass standards is indicated on the right. Arrowheads in 
   <bold>(C)</bold> indicate rZNS1-His monomer glycosylation pattern. Data represent the mean ± SEM of at least three independent experiments. P-values were calculated by one-way ANOVA, Bonferroni's: **P &lt; 0.01, ***P &lt; 0.001, n.s. not significant.
  </p>
 </caption>
 <alt-text id="at0050">Fig. 1</alt-text>
 <graphic xlink:href="gr1" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
